SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-010720
Filing Date
2017-11-02
Accepted
2017-11-02 17:07:16
Documents
67
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lnth10q-093017.htm 10-Q 1115740
2 EXHIBIT 31.1 lnth10q-093017ex311.htm EX-31.1 14941
3 EXHIBIT 31.2 lnth10q-093017ex312.htm EX-31.2 15010
4 EXHIBIT 32.1 lnth10q-093017ex321.htm EX-32.1 13708
  Complete submission text file 0001628280-17-010720.txt   4439452

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT lnth-20170930.xml EX-101.INS 815225
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20170930.xsd EX-101.SCH 39173
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20170930_cal.xml EX-101.CAL 76288
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20170930_def.xml EX-101.DEF 123081
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20170930_lab.xml EX-101.LAB 424252
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20170930_pre.xml EX-101.PRE 242023
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 171173397
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences